Ex-Incyte medical chemistry crew unveils Synnovation Therapeutics with $102M for the clinic

After spending nearly 20 years together in leadership roles at Incyte, helping bring to market five medicines, Wenqing Yao and Reid Huber are reuniting on a new biotech venture that will enter the clinic in the next few weeks.

The mission is quite personal for Yao, who’s a cancer survivor…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks